You are here

  • Home
  • Archive
  • Volume 97, Issue 5
  • Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims

Article metrics

Article menu
Download PDFPDF
Clinical
Original research
Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 20204135811
Nov 20204683634
Dec 20205440
Jan 202110975
Feb 20219585
Mar 20219355
Apr 20216013
May 20213753
Jun 2021532
Jul 202120149
Aug 202123189
Sep 202120116
Oct 202110623
Nov 202111985
Dec 202111772
Jan 2022155711
Feb 20227132
Mar 202211553
Apr 20229470
May 202211110
Jun 20228652
Jul 20228030
Aug 202210130
Sep 20227951
Oct 20229711
Nov 20227122
Dec 20224830
Jan 202311631
Feb 202311894
Mar 20234642
Apr 20233600
May 20234883
Jun 20235200
Jul 20235453
Aug 20237532
Sep 20231600
Oct 20236332
Nov 20233520
Dec 20234711
Jan 20249741
Feb 202412654
Mar 20243600
Total3812279147